Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes
Clinical trial NCT07487103 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07487103
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2026-12-01
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.